Interferon Signaling Is Frequently Downregulated in Melanoma

by Sara Alavi, Sara Alavi, Ashleigh Jacqueline Stewart, Ashleigh Jacqueline Stewart, Richard F. Kefford, Richard F. Kefford, Su Yin Lim, Su Yin Lim, Elena Shklovskaya, Elena Shklovskaya, Helen Rizos, Helen Rizos
Published 2018-06-01

Liquid biomarkers in melanoma: detection and discovery

by Su Yin Lim, Jenny H. Lee, Russell J. Diefenbach, Richard F. Kefford, Helen Rizos
Published 2018-01-01

Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma.

by Alexander M Menzies, Lauren E Haydu, Matteo S Carlino, Mary W F Azer, Peter J A Carr, Richard F Kefford, Georgina V Long
Published 2014-01-01

Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt/β-catenin signaling.

by Andy J Chien, Lauren E Haydu, Travis L Biechele, Rima M Kulikauskas, Helen Rizos, Richard F Kefford, Richard A Scolyer, Randall T Moon, Georgina V Long
Published 2014-01-01

p16INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors

by Stuart J. Gallagher, John F. Thompson, James Indsto, Lyndee L. Scurr, Margaret Lett, Bo-Fu Gao, Ruth Dunleavey, Graham J. Mann, Richard F. Kefford, Helen Rizos
Published 2008-11-01

Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing

by Gulietta M. Pupo, Suzanah C. Boyd, Carina Fung, Matteo S. Carlino, Alexander M. Menzies, Bernadette Pedersen, Peter Johansson, Nicholas K. Hayward, Richard F. Kefford, Richard A. Scolyer, Georgina V. Long, Helen Rizos
Published 2017-05-01

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA

by Russell J. Diefenbach, Jenny H. Lee, Alexander M. Menzies, Matteo S. Carlino, Georgina V. Long, Robyn P. M. Saw, Julie R. Howle, Andrew J. Spillane, Richard A. Scolyer, Richard F. Kefford, Helen Rizos
Published 2020-08-01

Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients

by Su Yin Lim, Jenny H. Lee, Sarah J. Welsh, Seong Beom Ahn, Edmond Breen, Alamgir Khan, Matteo S. Carlino, Alexander M. Menzies, Richard F. Kefford, Richard A. Scolyer, Georgina V. Long, Helen Rizos
Published 2017-11-01

Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma

by Elena Shklovskaya, Jenny H Lee, Su Yin Lim, Ashleigh Stewart, Bernadette Pedersen, Peter Ferguson, Robyn PM Saw, John F Thompson, Brindha Shivalingam, Matteo S Carlino, Richard A Scolyer, Alexander M Menzies, Georgina V Long, Richard F Kefford, Helen Rizos
Published 2020-11-01

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition

by Jenny H. Lee, Elena Shklovskaya, Su Yin Lim, Matteo S. Carlino, Alexander M. Menzies, Ashleigh Stewart, Bernadette Pedersen, Malama Irvine, Sara Alavi, Jean Y. H. Yang, Dario Strbenac, Robyn P. M. Saw, John F. Thompson, James S. Wilmott, Richard A. Scolyer, Georgina V. Long, Richard F. Kefford, Helen Rizos
Published 2020-04-01